Lower percentage of CD62L+ cells (P < 0.001) as well as lower expression of CD62L (P = 0.02) was found in neutrophils from CLL patients comparing to age-matched healthy controls (Table 1, Figure 1, Supplementary Figure 2 in on-line Supplement). Here, SELL is linked to B-cell chronic lymphocytic leukemia.